{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.07",
    "chg": -1.01,
    "chgp": "-2.52%",
    "dir": -1,
    "prev_price": "40.08",
    "mcapval": "1,717.57 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE551C01044",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "6.25 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "505931",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Update on board meeting",
      "datetime": "06-Aug-2026",
      "details": "The Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026 Date of Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Quarterly Results",
      "datetime": "30-Jul-2026",
      "details": "Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve To consider and approve Unaudited financial result for the Quarter ended on 30th June 2026 along with the Auditors Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday July 14 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR)",
      "datetime": "14-Jul-2026",
      "details": "The Board took on record and confirmed that in accordance with the terms of the aforesaid Special Resolution and the applicable provisions of Chapter V of the SEBI ICDR Regulations the allottees were required to bring in the differential upfront amount of Rs. 0.39 per Warrant (aggregating to Rs. 1810770/-) being the additional amount payable on the upfront 25% (Twenty-Five Per Cent) consideration on account of the re-computation of the issue price from Rs. 34.00 to Rs. 35.56 per Warrant within fifteen (15) days from the date of passing of the Special Resolution. Further Two Allottees have also paid the balance 75% (Seventy-Five Per Cent) of the Warrant Issue Price of differential consideration on or before July 13 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News